Monocyte to HDL-C Ratio as an Early Prognostic Marker of Pregnancy Complications: An Observational Study
Adolescência e Saúde · 03.11.2026 · 970-983
DOI: 10.67440/ahj.vi.3113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Adolescência e Saúde, online erschienen am 03.11.2026. Verfasst von Dr. Subhashini und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pregnancy is accompanied by substantial physiological, metabolic, inflammatory, and cardiovascular adaptations that are essential for normal maternal and fetal development. In some women, these adaptations are associated with pregnancy-related complications, including hypertensive disorders of pregnancy, preeclampsia, gestational diabetes mellitus (GDM), intrauterine growth restriction (IUGR), and preterm delivery, which may adversely affect maternal and perinatal outcomes. Increasing attention has been directed toward readily available biomarkers that can reflect the inflammatory and metabolic alterations occurring early in pregnancy. The monocyte to high-density lipoprotein cholesterol ratio (MHR) integrates two biologically relevant parameters: monocytes, which contribute to inflammatory processes, and HDL-C, which possesses anti-inflammatory, antioxidant, and endothelial-protective properties. The present study was undertaken to evaluate whether MHR measured during early pregnancy could serve as an accessible prognostic marker for subsequent pregnancy complications.
Methods
This observational study was conducted in the Department of Obstetrics and Gynaecology at SRM Medical College Hospital and Research Centre. Participant recruitment was carried out from July 2025 to March 2026. A total of 150 pregnant women were recruited during the first trimester after obtaining informed written consent. For consistency with the study eligibility criteria, pregnant women aged 18–40 years with singleton pregnancies were considered eligible for enrolment. Women with multiple pregnancies, pre-existing diabetes mellitus or chronic hypertension, recent use of lipid-lowering, anti-inflammatory or immunosuppressive medications, acute infection or inflammatory illness at the time of sampling, smoking or substance abuse during pregnancy, and those with incomplete antenatal follow-up were excluded. Early-pregnancy venous blood samples were assessed for hematological parameters, including absolute monocyte count, and biochemical parameters including HDL-C and other lipid-profile components. The MHR was calculated by dividing the absolute monocyte count by the serum HDL-C concentration. Following enrolment and baseline assessment, participants were followed prospectively until delivery, and the development of gestational hypertension or preeclampsia, GDM, IUGR, preterm delivery, and other clinically documented maternal or fetal complications was recorded. Statistical analysis was performed using appropriate descriptive and inferential statistical methods, with statistical significance considered at a p-value of
Zitieren
APA
Subhashini, D., R, D. S. K., & B, D. P. P. (2026). Monocyte to HDL-C Ratio as an Early Prognostic Marker of Pregnancy Complications: An Observational Study. Adolescência e Saúde, 970-983. https://doi.org/10.67440/ahj.vi.3113
Vancouver
Subhashini D, R DSK, B DPP. Monocyte to HDL-C Ratio as an Early Prognostic Marker of Pregnancy Complications: An Observational Study. Adolescência e Saúde. 2026:970-983. doi:10.67440/ahj.vi.3113
BibTeX
@article{Subhashini2026,
author = {Subhashini, Dr. and R, Dr Sajeetha Kumari and B, Dr. Poorna Pragathi},
title = {Monocyte to HDL-C Ratio as an Early Prognostic Marker of Pregnancy Complications: An Observational Study},
journal = {Adolescência e Saúde},
year = {2026},
pages = {970--983},
doi = {10.67440/ahj.vi.3113}
}
EUVIMED